AST SpaceMobile stock price slips after hours as BlueBird 7 launch timeline comes into focus
24 January 2026
1 min read

AST SpaceMobile stock price slips after hours as BlueBird 7 launch timeline comes into focus

New York, Jan 23, 2026, 19:57 EST — After-hours trading.

  • AST SpaceMobile shares dropped 2.4% during Friday’s regular trading and slipped further in after-hours.
  • The company aims to launch its BlueBird 7 satellite on Blue Origin’s New Glenn-3 in late February.
  • Investors are debating if AST can maintain a steady launch pace through 2026 as it moves closer to commercial service.

AST SpaceMobile (ASTS) shares dipped during after-hours Friday, easing off a volatile week as the market weighed the updated launch schedule for the company’s upcoming satellite. The stock ended regular trading down 2.4% at $113.57 and was last seen slipping another 0.3% to $113.19. 1

The timing is crucial since AST’s pitch is straightforward and tough: deploy enough satellites to transform regular phones into satellite phones once cell towers go down. Traders have zeroed in on launch dates as the closest thing to a scoreboard.

AST dubs it “direct-to-device” service, with satellites functioning like cell towers in orbit. The key is launching the hardware on time and demonstrating it can operate at scale.

AST announced Thursday that BlueBird 7 is set for a late February launch aboard Blue Origin’s New Glenn-3 from Launch Complex 36 at Cape Canaveral Space Force Station. The company aims to maintain a “multi-launcher” schedule, targeting one orbital launch every one to two months throughout 2026. They’re on track to deploy between 45 and 60 satellites by year’s end. “This launch advances our mission to bring space-based cellular broadband connectivity to everyday smartphones,” AST President Scott Wisniewski said in a statement. 2

Blue Origin also announced that New Glenn’s upcoming flight will deliver AST’s next-gen Block 2 BlueBird satellite into low Earth orbit, targeting a launch “no earlier than” late February. “We’re proud to have AST SpaceMobile as our customer on NG-3,” said Blue Origin CEO Dave Limp. 3

AST’s comments on its schedule have sparked trading interest as the company shifts focus from one-off satellite milestones to regular launches and, down the line, commercial coverage. Establishing a reliable launch rhythm would also give investors a clearer sense of how fast the constellation might expand.

Delays are nothing new in space ventures. Launch dates often slip due to readiness issues, weather, or problems with the rocket itself. Any postponement would push back AST’s coverage timeline and leave the stock exposed to headline risk.

As U.S. markets reopen Monday, investors will be closely watching for updates on the late-February target and any signals from either company about New Glenn-3’s launch readiness as the window draws near.

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Gilead stock jumps again as Trodelvy-Keytruda breast cancer data lands in NEJM
Previous Story

Gilead stock jumps again as Trodelvy-Keytruda breast cancer data lands in NEJM

Spotify stock jumps on Goldman upgrade as AI playlists and earnings draw closer
Next Story

Spotify stock jumps on Goldman upgrade as AI playlists and earnings draw closer

Go toTop